Healthcare -
Biotechnology - NASDAQ - US
$ 5.5
5.16 %
$ 49 M
Market Cap
-11.22
P/E
ICCC - GROSS PROFIT
Gross Profit ICCC - ImmuCell Corporation
4.4 M
LAST VALUE
-28.73%
2 YEAR CAGR
-3.28%
5 YEAR CAGR
3.69%
10 YEAR CAGR